Premium Information is available for this item - Upgrade for $1 a day
6505-01-015-2184
Clorazepate Dipotassium Capsules
6505010152184 010152184 TRANXENE CAPSULES NDC00074-3417-53
INC: 32230 Clorazepate Dipotassium Capsules
May 2023
5
Marketplace 6505-01-015-2184
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-015-2184 5+ Documents (More...)
6505-01-015-2184 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-015-2184
Every Day 6505-01-015-2184 RQST NE Related Documents 6505-01-015-2184 5+ Documents ( More... ) https
Clorazepate Dipotassium Capsules 010152184 Upgrade your Account Upgrade 6505-01-015-2184Clorazepate
Dipotassium Capsules6505010152184 010152184 TRANXENE www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-015
Clorazepate Dipotassium Capsules 010152184 Capsules6505145324721 145324721310770.9 TRANXENE Clorazepate
Dipotassium Capsules 430006092 010152184 6505-14-553-6698 Stock Numbers Related to 6505-01-015-2184
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-015-2184 Clorazepate Dipotassium Capsules 010152184
Capsules6505145324721 145324721310770.9 Contains 500 Ea00000000500EA NATO Stock Numbers Related to 6505-01-015-2184
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-013 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-015-2184
Clorazepate Dipotassium Capsules 010152184 your Account Upgrade 6505-01-015-2184Clorazepate Dipotassium
Restrictions 6505-01-015-2184
6505-01-015-2184 is a Clorazepate Dipotassium Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-015-2184
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-015-2184
- NASA (G502)
- Effective Date:
- 1 Apr 1991
- NASA (G572)
- Effective Date:
- 1 Apr 1991
- NASA (G652)
- Effective Date:
- 1 Apr 1991
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-015-2184
- Part Number
- Manufacturer
- Status
- NDC00074-3417-53
- Manufacturer
- 70048 - Abbott Laboratories (Active)
- Primary Buy
- Primary Buy
- TRANXENE CAPSULES
- 70048 - Abbott Laboratories (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-015-2184
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Capsule Type [AKJC]
- Any Acceptable
- Capsule Content Form [CQLS]
- Any Acceptable
- Active Medicament Medicinal Strength [AKJA]
- 3.750 Milligrams Clorazepate Dipotassium Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 500.000
Management Data 6505-01-015-2184
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Nov 1987
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 500 Ea
- 00000000500EA
- K
Similar Supply Items to 6505-01-015-2184
Freight Information 6505-01-015-2184
6505-01-015-2184 has freight characteristics.. 6505-01-015-2184 has a variance between NMFC and UFC when transported by rail and the description should be consulted.